Add To Watchlist
Share URL
About The Company
Description
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally.
Read More
Overview
Value
1
Growth
55
Health
40
Management
60
Analyst Opinion
57
Total
43
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low preportion of income is paid as dividend 0
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders 0
- No margin of safety at their current market price
Market Peers
PURE
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-269.70%
Revenue Growth (5 Year Average)
7.61%
Ratings Consensus
Neutral
Share Buybacks
-7.20%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0.1 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-23.79%
PE/Earnings Growth
N/A
Price/Book
4.82x
Growth
Growth Score
55
- ✔ 5 Year Average Earnings growth of 15.64% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 16.68% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of 7.61% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
7.61%
Earnings Growth
15.64%
Cashflow Growth
16.68%
Health
Health Score
40
Altman Z Score
N/A
Piostroski Score
2.00
Debt/Equity
N/Ax
Current Assets/Liabilities
6.72x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
N/Ax
Management
Management Score
60
Average Buybacks/Dilution
-7.20%
Recent Buybacks/Dilution
25.35%
5 Year Price Volitility
68.14%
Return On Assets
-99.34%
Return On Capital Employed
-60.47%
Return On Equity
-113.95%
Return On Free Cashflow
263.88%
Return On Investments
N/A
Analysts
Analyst Opinion
57
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
PURE Bioscience, Inc.
Currency
USD
Beta
0.075688
Vol Avg
60347
Ceo
Mr. Tom Y. Lee
Cik
0001006028
Cusip
Exchange
Other OTC
Full Time Employees
15
Industry
Household & Personal Products
Sector
Consumer Defensive
Ipo Date
2013-05-13
Address
9669 Hermosa Avenue
City
Rancho Cucamonga
State
CA
Country
US
Zip
91730
Phone
619 596 8600
All financial data provided by FMP